Butterfly Network, Inc. is proud to announce a successful funding round that raised $76,000,000, a milestone that will accelerate its mission to democratize access to vital clinical insights through groundbreaking ultrasound technology. Butterfly’s vision has always centered on making healthcare more accessible, efficient, and insightful by integrating innovative ultrasound technology with the power of artificial intelligence. With this significant injection of capital, the company is poised to further expand its reach, enhance its products, and fuel research and development initiatives that are set to redefine point-of-care diagnostics.
Leveraging its award-winning technology—recognized as the iQ3: Best Medical Technology Winner at the 2024 Prix Galien USA Awards—Butterfly Network is committed to offering high-quality, affordable, and easy-to-use ultrasound solutions that empower clinicians to make informed decisions quickly and confidently. This funding will support a range of critical developments, from furthering the integration of AI to refining the user experience across various care settings, including hospitals, community clinics, and even at home.
As Butterfly Network continues its journey to simplify complex imaging and deliver valuable clinical insights at the bedside, this financial boost is more than just capital—it represents trust from investors who believe in transforming healthcare through technology. The enhanced capabilities will not only bridge the gap between advanced diagnostics and everyday clinical practice but also ensure that both patients and healthcare providers benefit from timely and accurate information everywhere it is needed most. Butterfly’s vision of “seeing is knowing” is getting one step closer to becoming a reality for millions of patients worldwide.
